Long-term use of sedative and hypnotic medication.
Dunner
D L
DL
Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle 98105-6099, USA. ddunner@u.washington.edu
D017277:Drug Approval; D005069:Evaluation Studies as Topic; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects*; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D011358:Product Surveillance, Postmarketing / Q000706:statistics & numerical data; D011367:Professional Staff Committees; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D014229:Triazolam / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D006993:Hypnotics and Sedatives; D014229:Triazolam